Structure/Function Claims vs. Disease Claims: What Supplement Brands Need to Know

The line between structure/function language and disease claims is one of the most consequential distinctions in supplement marketing. A single word change on a label, website, or ad can shift how FDA classifies a product. Brands that understand the difference can market more confidently while avoiding claims that create regulatory exposure.

What is a structure/function claim under FDA rules?

Structure/function claims describe a nutrient or dietary ingredient's role in maintaining normal structure or function of the human body. Examples include statements that a product "supports immune health," "promotes regularity," or "helps maintain healthy cholesterol levels already within the normal range." These claims must be truthful, not misleading, and substantiated.

Dietary supplement firms may make structure/function claims without FDA pre-approval, but they must submit a notification to FDA within 30 days of first marketing the claim and include a mandatory disclaimer on the label. FDA structure/function claims guidance describes notification requirements and acceptable claim formats.

What makes a claim a disease claim?

FDA considers a claim to be a disease claim when it explicitly or implicitly suggests that a product can diagnose, cure, mitigate, treat, or prevent a disease. Named diseases — cancer, diabetes, COVID-19, depression — are obvious triggers. But implied disease claims can arise from symptoms, abnormal lab values, or images that consumers associate with a specific condition.

• "Reduces joint inflammation" may imply treatment of inflammatory disease rather than general structure/function support.
• "Lowers blood sugar" can cross the line unless carefully qualified and supported as a structure/function statement.
• "Relieves migraine pain" typically suggests treatment of a disease state.
• Before/after photos showing reversal of a medical condition may imply disease treatment.
• References to prescription drug alternatives often signal an implied drug claim.

Why do disease claims matter for supplement brands?

Products intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease are generally drugs under the Federal Food, Drug, and Cosmetic Act. Unless a drug claim is supported by FDA approval, marketing a supplement with disease claims can result in warning letters, product seizures, import detentions, and reputational harm. The regulatory consequence is not merely a labeling fix — it can affect the entire product's legal status.

Health claims and qualified health claims are separate categories

Authorized health claims and qualified health claims are FDA-reviewed statements linking a substance to disease risk reduction. They are not the same as structure/function claims and require specific regulatory authorization or qualified language. Brands sometimes confuse "supports heart health" (structure/function) with an authorized health claim about reducing heart disease risk — the substantiation and regulatory pathways differ significantly.

How does FDA evaluate implied disease claims?

FDA looks at the net impression of all labeling and advertising, including context, images, testimonials, and surrounding copy. A phrase that might be acceptable in isolation can become a disease claim when paired with disease-related hashtags, patient testimonials, or references to symptoms tied to a known condition. This holistic review is why brands should evaluate websites, social posts, and influencer content alongside primary packaging.

What disclaimer is required for structure/function claims?

The standard disclaimer — that the FDA has not evaluated the statement and that the product is not intended to diagnose, treat, cure, or prevent any disease — must appear on the label in required proximity to the claim. Omitting or obscuring the disclaimer is a common compliance gap. The disclaimer does not convert a disease claim into a structure/function claim; it only accompanies permissible structure/function statements.

How can brands review claims before launch?

A practical review process maps each marketing statement to claim type, identifies implied disease language, confirms substantiation files, and verifies disclaimer placement. Natascia Taken, Esq. recommends maintaining a claims library with approved wording, forbidden synonyms, and substantiation references so sales, creative, and affiliate teams work from the same source of truth. Periodic audits of live web copy catch drift that occurs after initial approval.

What are practical examples of compliant vs. risky wording?

"Supports digestive health" may be a structure/function claim if substantiated and accompanied by the required disclaimer. "Treats irritable bowel syndrome" is a disease claim. "Helps you lose weight fast" may imply treatment of obesity depending on context. "Promotes healthy energy levels" may be acceptable; "cures chronic fatigue" crosses into disease territory. The difference often turns on whether the language addresses a normal body function or a pathological condition.

Red flag words that frequently trigger FDA scrutiny include cure, treat, prevent, diagnose, restore, reverse, and eliminate when paired with symptoms consumers associate with disease. Qualifiers such as "may help" do not automatically convert a disease claim into a structure/function claim if the overall net impression still suggests therapeutic benefit for a disease state.

Consumer perception surveys and focus groups sometimes reveal that marketing language communicates disease treatment even when internal teams classify copy as structure/function. Testing net impression before launch can surface risky wording early.

This overview is for educational purposes and does not constitute legal advice. FDA evaluates claims in context, and outcomes depend on specific product facts and marketing materials.